+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Europe Compounding Pharmacies Market: Analysis By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology, Others), By End Users, By Type, By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)

  • PDF Icon

    Report

  • 275 Pages
  • December 2022
  • Region: Europe
  • Azoth Analytics
  • ID: 5711380
The European Compounding Pharmacies Market is projected to display significant growth represented by a CAGR of 8.25% during 2023-2028. The European Compounding Pharmacies Market was valued at USD 3314.80 Million in the year 2021 with Italy holding the largest market share. In terms of segments, the availability of a diverse range of compounded formulas for dermatological purposes will drive segment expansion. Patients who are allergic to commercial pharmaceuticals might benefit from dermatology customised treatments.

The European Compounding Pharmacies market is a consolidated market. The major players in the market like Athenex, Baxter International, Fagron, Grifols, Capsa Healthcare, Nephron Pharmaceuticals, B. Braun, Fresenius, McKesson and Omnicell have a large geographical presence and a highly diversified product portfolio. These players focus on R&D, a large product portfolio, a wide geographical presence and an aggressive acquisition strategy.

Italy is holding the largest market share and is growing at the fastest rate during the forecast period, owing to the rising prevalence of therapeutic areas as well as the widespread use of pain management in developed countries like the United Kingdom and Germany.

The United Kingdom Compounding Pharmacies market has witnessed growth in recent years due to increased investments and offtake agreements among new companies to cope with new market strategies.

France is a lucrative market because of the presence of several compounding pharmacies, high adoption among people, and scarcity of many drugs, which are key factors for market growth.

Scope of the Report

  • The report analyses the Europe Compounding Pharmacies Market by Value (USD Million).
  • The report analyses the Europe Compounding Pharmacies by Therapeutic Area (Hormone Replacement, Pain Management, Dermatology, and Other Sources).
  • The report analyses the Europe Compounding Pharmacies Market), by End Users (Adult, Pediatric, Others, Geriatric, Veterinary).
  • The report analyses the Europe Compounding Pharmacies Market by Type (Oral, Topical, Ophthalmic, Injecs, and Others Types).
  • The Europe Compounding Pharmacies Market has been analysed by Country (United Kingdom, Germany, France, Italy, Spain, Russia, Turkey, Benelux, Nordic, and Rest of Europe).
  • The key insights of the report have been presented through the leading company shares. Also, the attractiveness of the market has been presented by country, by Therapeutic Area, by End Users, by Type.
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, and recent developments. The companies analysed in the report include Athenex, Baxter International, Fagron, Grifols, Capsa Healthcare, Nephron Pharmaceuticals, B. Braun, Fresenius, McKesson and Omnicell.
  • The report presents the analysis of the European Compounding Pharmacies Market for the historical period of 2018-2021, the estimated year 2022 and the forecast period of 2023-2028.

Key Target Audience

  • Healthcare and Pharmaceutical Companies
  • End Users (Adult & Veterinary)
  • Research and Development (R&D) Organizations
  • Government Bodies & Regulating Authorities
  • Investment Banks and Equity Firms
Frequently Asked Questions about the European Compounding Pharmacies Market

What is the estimated value of the European Compounding Pharmacies Market?

The European Compounding Pharmacies Market was estimated to be valued at $3.56 Billion in 2022.

What is the growth rate of the European Compounding Pharmacies Market?

The growth rate of the European Compounding Pharmacies Market is 8.1%, with an estimated value of $5.69 Billion by 2028.

What is the forecasted size of the European Compounding Pharmacies Market?

The European Compounding Pharmacies Market is estimated to be worth $5.69 Billion by 2028.

Table of Contents

1. Introduction
1.1 Compounding Pharmacies Market Overview
1.2 Scope of Research
2. Executive Summary
2.1 Market Snapshot
2.2 Country Insights
2.3 Market Ecosystem Factors
3. Research Methodology
3.1 Data Collection Process
3.3 Market Size Calculation-Top-to-Bottom
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Analyst Recommendations
4.5 Trends
4.6 Impact Analysis
5. COVID-19 Impact Assessment
5.1 Degree of Impact of COVID-19 on Compounding Pharmacies Market
6. Porter's Five Forces analysis
7. Macro Economic Indicator Outlook
7.1 GDP per capita growth (USD)
7.2 Breakdown of Total Healthcare Expenditure (THE) in Europe - 2021
7.3Current Healthcare Expenditure
7.4 Pharmaceutical Spending/capita
8. Europe compounding Pharmacies Market
8.1 Impact Analysis of Macro Economic Factors on Compounding Pharmacies Market
8.2 Snapshot
8.3 Europe Compounding Pharmacies Market: Market Value Assessment
8.4 Market Summary
9. Europe Compounding Pharmacies Market Trend And Forecast Analysis, 2018-2028, By Therapeutic Area
9.1 Europe Compounding Pharmacies Market Trend And Forecast Analysis, Therapeutic Area: Snapshot
9.2 Hormone Replacement
9.3 Pain Management
9.4 Dermatology
9.5 Other Sources
10. Europe Compounding Pharmacies Market Trend And Forecast Analysis, 2018-2028, By End Users
10.1 Europe Compounding Pharmacies Market Trend And Forecast Analysis, End Users: Snapshot
10.2 Adult
10.3 Paediatric
10.4 Geriatric
10.5 Veterinary
11. Europe Compounding Pharmacies Market Trend And Forecast Analysis, 2018-2028, By Type
11.1 Europe Compounding Pharmacies Market Trend And Forecast Analysis, By Type: Snapshot
11.2 Oral
11.3 Topical
11.4 Ophthalmic
11.5 Injectables
11.6 Other Types
12. Europe Compounding Pharmacies Market Trend And Forecast Analysis, 2018-2028, By Country
12.1 United Kingdom Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.1.1 By Therapeutic Area
12.1.2 By End Users
12.1.3 By Type
12.2 Germany Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.2.1 By Therapeutic Area
12.2.2 By End Users
12.2.3 By Type
12.3 France Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.3.1 By Therapeutic Area
12.3.2 By End Users
12.3.3 By Type
12.4 Italy Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.4.1 By Therapeutic Area
12.4.2 By End Users
12.4.3 By Type
12.5 Spain Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.5.1 By Therapeutic Area
12.5.2 By End Users
12.5.3 By Type
12.6 Russia Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.6.1 By Therapeutic Area
12.6.2 By End Users
12.6.3 By Type
12.7 Turkey Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.7.1 By Therapeutic Area
12.7.2 By End Users
12.7.3 By Type
12.8 Benelux Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.8.1 By Therapeutic Area
12.8.2 By End Users
12.8.3 By Type
12.9 Nordic Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.9.1 By Therapeutic Area
12.9.2 By End Users
12.9.3 By Type
12.10 Rest of Europe Compounding Pharmacies Market Trend And Forecast Analysis: Segmentation
12.10.1 By Therapeutic Area
12.10.2 By End Users
12.10.3 By Type
13. Competitive Positioning
13.1 Companies’ Product Positioning
13.2 Market Position Matrix
13.3 Market Share Analysis of Compounding Pharmacies Market
13.4 Company Profiles
13.4.1 Athenex
13.4.2 Baxter International
13.4.3 Fagron
13.4.4 Grifols
13.4.5 Capsa Healthcare
13.4.6 Nephron Pharmaceuticals
13.4.7 B. Braun
13.4.8 Fresenius
13.4.9 McKesson
13.4.10 Omnicell
List of Figures
Figure 1: Compounding Pharmacies Market for next 7 years (in USD Millions)
Figure 2: Compounding Pharmacies Market Size, By Type, 2018 & 2028 (USD Million)
Figure 3: Compounding Pharmacies Market Size, By Type, 2018 & 2028 (USD Million)
Figure 4: At a CAGR of 8.25% during 2023-2028, the Europe market value is expected to reach USD 5699.62 Million in 2028
Figure 5: Value sales of Compounding Pharmacies is expected to sustain a staggering sales of 5699.62 million in 2028
Figure 6: Europe Compounding Pharmacies Market Size, By Value, 2015-2021(USD Million)
Figure 7: Europe Compounding Pharmacies Market Size, By Value, 2022-2028 (USD Million)
Figure 8: Europe Compounding Pharmacies Market Share, By Type, 2028 (%)
Figure 9: Europe Compounding Pharmacies Market CAGR, Therapeutic Area, By Value, 2015-2021, 2023-2028 (%)
Figure 10: Basis Point Analysis of Europe Compounding Pharmacies Market, Therapeutic Area (2022,2028)
Figure 11: Market Opportunity Analysis of Europe Compounding Pharmacies Market, Therapeutic Area (2023-2028)
Figure 12: Europe Compounding Pharmacies Market Size, By Hormone Replacement, By Value, 2015-2021 (USD Million)
Figure 13: Europe Compounding Pharmacies Market Size, By Hormone Replacement, By Value, 2022-2028 (USD Million)
Figure 14: Europe Compounding Pharmacies Market Absolute Opportunity, By Hormone Replacement, 2023-2028 (USD Million)
Figure 15: Europe Compounding Pharmacies Market Size, By Pain Management, By Value, 2015-2021 (USD Million)
Figure 16: Europe Compounding Pharmacies Market Size, By Pain Management, By Value, 2022-2028 (USD Million)
Figure 17: Europe Compounding Pharmacies Market Absolute Opportunity, By Pain Management, 2023-2028 (USD Million)
Figure 18: Europe Compounding Pharmacies Market Size, By Dermatology, By Value, 2015-2021 (USD Million)
Figure 19: Europe Compounding Pharmacies Market Size, By Dermatology, By Value, 2022-2028 (USD Million)
Figure 20: Europe Compounding Pharmacies Market Absolute Opportunity, By Dermatology, 2023-2028 (USD Million)
Figure 21: Europe Compounding Pharmacies Market Size, By Other Sources, By Value, 2015-2021 (USD Million)
Figure 22: Europe Compounding Pharmacies Market Size, By Other Sources, By Value, 2022-2028 (USD Million)
Figure 23: Europe Compounding Pharmacies Market Absolute Opportunity, By Other Sources, 2023-2028 (USD Million)
Figure 24: Europe Compounding Pharmacies Market CAGR, By End Users, By Value, 2015-2021, 2023-2028 (%)
Figure 25: Basis Point Analysis of Europe Compounding Pharmacies Market, By End Users (2022,2028)
Figure 26: Market Opportunity Analysis of Europe Compounding Pharmacies Market, By End Users (2023-2028)
Figure 27: Europe Compounding Pharmacies Market Size, By Adult, By Value, 2015-2021 (USD Million)
Figure 28: Europe Compounding Pharmacies Market Size, By Adult, By Value, 2022-2028 (USD Million)
Figure 29: Europe Compounding Pharmacies Market Absolute Opportunity, By Adult, 2023-2028 (USD Million)
Figure 30: Europe Compounding Pharmacies Market Size, By Pediatric, By Value, 2015-2021 (USD Million)
Figure 31: Europe Compounding Pharmacies Market Size, Pediatric, By Value, 2022-2028 (USD Million)
Figure 32: Europe Compounding Pharmacies Market Absolute Opportunity, By Pediatric, 2023-2028 (USD Million)
Figure 33: Europe Compounding Pharmacies Market Size, By Geriatric, By Value, 2015-2021 (USD Million)
Figure 34: Europe Compounding Pharmacies Market Size, By Geriatric, By Value, 2022-2028 (USD Million)
Figure 35: Europe Compounding Pharmacies Market Absolute Opportunity, By Geriatric, 2023-2028 (USD Million)
Figure 36: Europe Compounding Pharmacies Market Size, By Veterinary, By Value, 2015-2021 (USD Million)
Figure 37: Europe Compounding Pharmacies Market Size, By Veterinary, By Value, 2022-2028 (USD Million)
Figure 38: Europe Compounding Pharmacies Market Absolute Opportunity, By Veterinary, 2023-2028 (USD Million)
Figure 39: Europe Compounding Pharmacies Market CAGR, By Type, By Value, 2015-2021, 2023-2028 (%)
Figure 40: Basis Point Analysis of Europe Compounding Pharmacies Market, By Type (2022,2028)
Figure 41: Market Opportunity Analysis of Europe Compounding Pharmacies Market, By Type (2023-2028)
Figure 42: Europe Compounding Pharmacies Market Size, By Oral, By Value, 2015-2021 (USD Million)
Figure 43: Europe Compounding Pharmacies Market Size, By Oral, By Value, 2022-2028 (USD Million)
Figure 44: Europe Compounding Pharmacies Market Absolute Opportunity, By Oral, 2023-2028 (USD Million)
Figure 45: Europe Compounding Pharmacies Market Size, By Topical, By Value, 2015-2021 (USD Million)
Figure 46: Europe Compounding Pharmacies Market Size, By Topical, By Value, 2022-2028 (USD Million)
Figure 47: Europe Compounding Pharmacies Market Absolute Opportunity, By Topical, 2023-2028 (USD Million)
Figure 48: Europe Compounding Pharmacies Market Size, By Ophthalmic, By Value, 2015-2021 (USD Million)
Figure 49: Europe Compounding Pharmacies Market Size, By Ophthalmic, By Value, 2022-2028 (USD Million)
Figure 50: Europe Compounding Pharmacies Market Absolute Opportunity, By Ophthalmic, 2023-2028 (USD Million)
Figure 51: Europe Compounding Pharmacies Market Size, By InjecFigures, By Value, 2015-2021 (USD Million)
Figure 52: Europe Compounding Pharmacies Market Size, By InjecFigures, By Value, 2022-2028 (USD Million)
Figure 53: Europe Compounding Pharmacies Market Absolute Opportunity, By InjecFigures, 2023-2028 (USD Million)
Figure 54: Europe Compounding Pharmacies Market Size, By Other Types, By Value, 2015-2021 (USD Million)
Figure 55: Europe Compounding Pharmacies Market Size, By Other Types, By Value, 2022-2028 (USD Million)
Figure 56: Europe Compounding Pharmacies Market Absolute Opportunity, By Other Types, 2023-2028 (USD Million)
Figure 57: United Kingdom Compounding Pharmacies Market Size, By Value, 2015-2021 (USD Million)
Figure 58: United Kingdom Compounding Pharmacies Market Size, By Value, 2022-2028 (USD Million)
Figure 59: United Kingdom Compounding Pharmacies Market Share, Therapeutic Area, 2021 (%)
Figure 60: United Kingdom Compounding Pharmacies Market Size, By Hormone Replacement, By Value, 2015-2021 (USD Million)
Figure 61: United Kingdom Compounding Pharmacies Market Size, By Hormone Replacement, By Value, 2022-2028 (USD Million)
Figure 62: United Kingdom Hormone Replacement Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 63: United Kingdom Compounding Pharmacies Market Size, By Pain Management, By Value, 2015-2021 (USD Million)
Figure 64: United Kingdom Compounding Pharmacies Market Size, By Pain Management, By Value, 2022-2028 (USD Million)
Figure 65: United Kingdom Pain Management Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 66: United Kingdom Compounding Pharmacies Market Size, By Dermatology, By Value, 2015-2021 (USD Million)
Figure 67: United Kingdom Compounding Pharmacies Market Size, By Dermatology, By Value, 2022-2028 (USD Million)
Figure 68: United Kingdom Dermatology Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 69: United Kingdom Compounding Pharmacies Market Size, By Other Sources, By Value, 2015-2021 (USD Million)
Figure 70: United Kingdom Compounding Pharmacies Market Size, By Other Sources, By Value, 2022-2028 (USD Million)
Figure 71: United Kingdom Other Sources Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 72: United Kingdom Compounding Pharmacies Market Size, By Adult, By Value, 2015-2021 (USD Million)
Figure 73: United Kingdom Compounding Pharmacies Market Size, By Adult, By Value, 2022-2028 (USD Million)
Figure 74: United Kingdom Adult Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 75: United Kingdom Compounding Pharmacies Market Size, By Pediatric, By Value, 2015-2021 (USD Million)
Figure 76: United Kingdom Compounding Pharmacies Market Size, Pediatric, By Value, 2022-2028 (USD Million)
Figure 77: United Kingdom Pediatric Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 78: United Kingdom Compounding Pharmacies Market Size, By Geriatric, By Value, 2015-2021 (USD Million)
Figure 79: United Kingdom Compounding Pharmacies Market Size, By Geriatric, By Value, 2022-2028 (USD Million)
Figure 80: United Kingdom Geriatric Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 81: United Kingdom Compounding Pharmacies Market Size, By Veterinary, By Value, 2015-2021 (USD Million)
Figure 82: United Kingdom Compounding Pharmacies Market Size, By Veterinary, By Value, 2022-2028 (USD Million)
Figure 83: United Kingdom Veterinary Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 84: United Kingdom Compounding Pharmacies Market Size, By Oral, By Value, 2015-2021 (USD Million)
Figure 85: United Kingdom Compounding Pharmacies Market Size, By Oral, By Value, 2022-2028 (USD Million)
Figure 86: United Kingdom Oral Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 87: United Kingdom Compounding Pharmacies Market Size, By Topical, By Value, 2015-2021 (USD Million)
Figure 88: United Kingdom Compounding Pharmacies Market Size, By Topical, By Value, 2022-2028 (USD Million)
Figure 89: United Kingdom Topical Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 90: United Kingdom Compounding Pharmacies Market Size, By Ophthalmic, By Value, 2015-2021 (USD Million)
Figure 91: United Kingdom Compounding Pharmacies Market Size, By Ophthalmic, By Value, 2022-2028 (USD Million)
Figure 92: United Kingdom Ophthalmic Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 93: United Kingdom Compounding Pharmacies Market Size, By InjecFigures, By Value, 2015-2021 (USD Million)
Figure 94: United Kingdom Compounding Pharmacies Market Size, By InjecFigures, By Value, 2022-2028 (USD Million)
Figure 95: United Kingdom InjecFigures Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 96: United Kingdom Compounding Pharmacies Market Size, By Other Types, By Value, 2015-2021 (USD Million)
Figure 97: United Kingdom Compounding Pharmacies Market Size, By Other Types, By Value, 2022-2028 (USD Million)
Figure 98: United Kingdom Other Types Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 99: Germany Compounding Pharmacies Market Size, By Value, 2015-2021 (USD Million)
Figure 100: Germany Compounding Pharmacies Market Size, By Value, 2022-2028 (USD Million)
Figure 101: Germany Compounding Pharmacies Market Share, Therapeutic Area, 2021 (%)
Figure 102: Germany Compounding Pharmacies Market Size, By Hormone Replacement, By Value, 2015-2021 (USD Million)
Figure 103: Germany Compounding Pharmacies Market Size, By Hormone Replacement, By Value, 2022-2028 (USD Million)
Figure 104: Germany Hormone Replacement Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 105: Germany Compounding Pharmacies Market Size, By Pain Management, By Value, 2015-2021 (USD Million)
Figure 106: Germany Compounding Pharmacies Market Size, By Pain Management, By Value, 2022-2028 (USD Million)
Figure 107: Germany Pain Management Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 108: Germany Compounding Pharmacies Market Size, By Dermatology, By Value, 2015-2021 (USD Million)
Figure 109: Germany Compounding Pharmacies Market Size, By Dermatology, By Value, 2022-2028 (USD Million)
Figure 110: Germany Dermatology Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 111: Germany Compounding Pharmacies Market Size, By Other Sources, By Value, 2015-2021 (USD Million)
Figure 112: Germany Compounding Pharmacies Market Size, By Other Sources, By Value, 2022-2028 (USD Million)
Figure 113: Germany Other Sources Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 114: Germany Compounding Pharmacies Market Size, By Adult, By Value, 2015-2021 (USD Million)
Figure 115: Germany Compounding Pharmacies Market Size, By Adult, By Value, 2022-2028 (USD Million)
Figure 116: Germany Adult Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 117: Germany Compounding Pharmacies Market Size, By Pediatric, By Value, 2015-2021 (USD Million)
Figure 118: Germany Compounding Pharmacies Market Size, Pediatric, By Value, 2022-2028 (USD Million)
Figure 119: Germany Pediatric Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 120: Germany Compounding Pharmacies Market Size, By Geriatric, By Value, 2015-2021 (USD Million)
Figure 121: Germany Compounding Pharmacies Market Size, By Geriatric, By Value, 2022-2028 (USD Million)
Figure 122: Germany Geriatric Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 123: Germany Compounding Pharmacies Market Size, By Veterinary, By Value, 2015-2021 (USD Million)
Figure 124: Germany Compounding Pharmacies Market Size, By Veterinary, By Value, 2022-2028 (USD Million)
Figure 125: Germany Veterinary Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 126: Germany Compounding Pharmacies Market Size, By Oral, By Value, 2015-2021 (USD Million)
Figure 127: Germany Compounding Pharmacies Market Size, By Oral, By Value, 2022-2028 (USD Million)
Figure 128: Germany Oral Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 129: Germany Compounding Pharmacies Market Size, By Topical, By Value, 2015-2021 (USD Million)
Figure 130: Germany Compounding Pharmacies Market Size, By Topical, By Value, 2022-2028 (USD Million)
Figure 131: Germany Topical Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 132: Germany Compounding Pharmacies Market Size, By Ophthalmic, By Value, 2015-2021 (USD Million)
Figure 133: Germany Compounding Pharmacies Market Size, By Ophthalmic, By Value, 2022-2028 (USD Million)
Figure 134: Germany Ophthalmic Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 135: Germany Compounding Pharmacies Market Size, By InjecFigures, By Value, 2015-2021 (USD Million)
Figure 136: Germany Compounding Pharmacies Market Size, By InjecFigures, By Value, 2022-2028 (USD Million)
Figure 137: Germany InjecFigures Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 138: Germany Compounding Pharmacies Market Size, By Other Types, By Value, 2015-2021 (USD Million)
Figure 139: Germany Compounding Pharmacies Market Size, By Other Types, By Value, 2022-2028 (USD Million)
Figure 140: Germany Other Types Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 141: France Compounding Pharmacies Market Size, By Value, 2015-2021 (USD Million)
Figure 142: France Compounding Pharmacies Market Size, By Value, 2022-2028 (USD Million)
Figure 143: France Compounding Pharmacies Market Share, Therapeutic Area, 2021 (%)
Figure 144: France Compounding Pharmacies Market Size, By Hormone Replacement, By Value, 2015-2021 (USD Million)
Figure 145: France Compounding Pharmacies Market Size, By Hormone Replacement, By Value, 2022-2028 (USD Million)
Figure 146: France Hormone Replacement Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 147: France Compounding Pharmacies Market Size, By Pain Management, By Value, 2015-2021 (USD Million)
Figure 148: France Compounding Pharmacies Market Size, By Pain Management, By Value, 2022-2028 (USD Million)
Figure 149: France Pain Management Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 150: France Compounding Pharmacies Market Size, By Dermatology, By Value, 2015-2021 (USD Million)
Figure 151: France Compounding Pharmacies Market Size, By Dermatology, By Value, 2022-2028 (USD Million)
Figure 152: France Dermatology Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 153: France Compounding Pharmacies Market Size, By Other Sources, By Value, 2015-2021 (USD Million)
Figure 154: France Compounding Pharmacies Market Size, By Other Sources, By Value, 2022-2028 (USD Million)
Figure 155: France Other Sources Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 156: France Compounding Pharmacies Market Size, By Adult, By Value, 2015-2021 (USD Million)
Figure 157: France Compounding Pharmacies Market Size, By Adult, By Value, 2022-2028 (USD Million)
Figure 158: France Adult Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 159: France Compounding Pharmacies Market Size, By Pediatric, By Value, 2015-2021 (USD Million)
Figure 160: France Compounding Pharmacies Market Size, Pediatric, By Value, 2022-2028 (USD Million)
Figure 161: France Pediatric Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 162: France Compounding Pharmacies Market Size, By Geriatric, By Value, 2015-2021 (USD Million)
Figure 163: France Compounding Pharmacies Market Size, By Geriatric, By Value, 2022-2028 (USD Million)
Figure 164: France Geriatric Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 165: France Compounding Pharmacies Market Size, By Veterinary, By Value, 2015-2021 (USD Million)
Figure 166: France Compounding Pharmacies Market Size, By Veterinary, By Value, 2022-2028 (USD Million)
Figure 167: France Veterinary Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 168: France Compounding Pharmacies Market Size, By Oral, By Value, 2015-2021 (USD Million)
Figure 169: France Compounding Pharmacies Market Size, By Oral, By Value, 2022-2028 (USD Million)
Figure 170: France Oral Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 171: France Compounding Pharmacies Market Size, By Topical, By Value, 2015-2021 (USD Million)
Figure 172: France Compounding Pharmacies Market Size, By Topical, By Value, 2022-2028 (USD Million)
Figure 173: France Topical Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 174: France Compounding Pharmacies Market Size, By Ophthalmic, By Value, 2015-2021 (USD Million)
Figure 175: France Compounding Pharmacies Market Size, By Ophthalmic, By Value, 2022-2028 (USD Million)
Figure 176: France Ophthalmic Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 177: France Compounding Pharmacies Market Size, By InjecFigures, By Value, 2015-2021 (USD Million)
Figure 178: France Compounding Pharmacies Market Size, By InjecFigures, By Value, 2022-2028 (USD Million)
Figure 179: France InjecFigures Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)
Figure 180: France Compounding Pharmacies Market Size, By Other Types, By Value, 2015-2021 (USD Million)
Figure 181: France Compounding Pharmacies Market Size, By Other Types, By Value, 2022-2028 (USD Million)
Figure 182: France Other Types Compounding Pharmacies Footprint in Europe Market, 2021 (% of Europe Market)

Methodology

Loading
LOADING...